Xylella Fastidiosa Active Containment Through a multidisciplinary-Oriented Research Strategy

International conference: “Xylella Fastidiosa: Finding Answers to a global problem” and XF-ACTORS Annual Meeting to be held next November in Palma de Mallorca, Spain. Call for abstract for the International Conference to be submitted here

New deadline for the abstract submission – May 31, 2017. 

EFSA, the European Food and Safety Agency, has announced the organization of a major European conference on Xylella fastidiosa in Palma de Mallorca, in the Balearic Island, scheduled for next November 13-15, 2017. The International conference will be followed, on November 15-16, by the first Annual Meeting of the H2020 project XF-ACTORS.

Organized jointly with the University of the Balearic Islands, the Euphresco network and the EU-funded consortia POnTE and XF-ACTORS, the international conference Xylella fastidiosa: finding answers to a global phenomenon will be attended by experts, researchers and stakeholders from all over the world, with a particular focus on the outcome of the research programs ongoing in the countries that have experimented major outbreaks in the past years.

Scientists and researchers willing to participate as speakers must submit an abstract by 30 April 2017. For all further information on the conference, please check the EFSA event page.

The closure of the International Conference will be followed by the consortium annual meetings of the ongoing H2020 projects dealing with Xylella fastidiosa: XF-ACTORS and POnTE. A one day meeting on November 15-16 will be jointly organized between the two Consortia, to promote and strengthen effective research collaborations and common dissemination strategies between the two projects towards common objectives.

Started in November 2016, XF-ACTORS is the first research project in Europe entirely devoted to develop a multidisciplinary research program on the bacterium Xylella fastidiosa. The final objective of XF-ACTORS is to provide sustainable management strategies through an integrated research program which will investigate the biology and the genetics of the bacterium, the ecology of the vector(s) and the different factors contributing to the disease epidemiology. XF-ACTORS involves a large consortium composed by 29 Partners and Research Institutions, including 4 non-European research centers from USA, Brazil, Costa Rica and Taiwan.

Follow us on social networks!

Stay updated with XF-ACTORS news!